InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: jimtash post# 17763

Sunday, 07/14/2013 10:25:28 AM

Sunday, July 14, 2013 10:25:28 AM

Post# of 30046
GCDx is not calling their test DR-70 or Onko-Sure. So the trademarks and names are moot.

The patent application was rejected twice. Now it's being reviewed again by the same examiner. Did Radient get their act together this time? Flip of the coin, IMO.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.